June 13, 2022, 7:06 p.m. EDT

3 Good Penny Stocks to Watch During the Market Crash

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Ginkgo Bioworks Holdings Inc. (DNA)
  • X
    Applied UV Inc. (AUVI)
  • X
    SOS Ltd. ADR (SOS)

or Cancel Already have a watchlist? Log In

Jun 13, 2022 (Penny Stocks via COMTEX) -- Top Penny Stocks to Watch As the Market Crashes Again

With another major market crash on June 13th, which penny stocks are investors watching right now? Well, it is tough to say as there is so much movement in the stock market right now. But, to understand this, all we have to do is look at why the market is crashing right now.

[Read More] Penny Stocks to Buy Right Now? 3 to Watch in Mid-June 2022

For starters, we see that the fear of rising interest rates is causing major bearish sentiment. With inflation rising to highs not seen in years, the Fed is working quickly to combat it. So as investors, it is our job to make sure that we take advantage of these moves no matter what direction the market is going. Considering that, let's take a look at three hot penny stocks to watch right now.

3 Penny Stocks to Add to Your Watchlist Right Now

  1. Gingko Bioworks Holdings Inc. ( NYSE: DNA )

  2. Applied UV Inc. ( NASDAQ: AUVI )

  3. Sos Ltd. ( NYSE: SOS )

Gingko Bioworks Holdings Inc. /zigman2/quotes/226092395/composite DNA -12.83%

While shares of DNA stock fell by around 15% today, we did see a 3.3% rise during after hours. And, in the past five days, shares of DNA stock have fallen by around 30%. Despite this, we are seeing small glimpses of bullish sentiment on occasion which means that DNA could be worth taking a closer look at right now.

The most recent news from the company came on June 10th when it announced its party-cation in the Goldman Sachs 43rd Annual Global Healthcare Conference. This conference will take place on June 15th 2022 and will be the next time we see what Gingko is up to. Besides this, not much news has come out of the company recently. A few days before this, the company did announce that it is partnering with Novo Nordisk to build expression systems for pharmaceutical products.

With this in mind, do you think DNA stock is worth buying or not?

Applied UV Inc. /zigman2/quotes/220244459/composite AUVI +1.70%

Another penny stock that gained during after hours trading on June 13th is AUVI stock. In after hours, shares of AUVI stock managed to shoot up by over 5.5% following a 2.5% drop. The main reason for this comes as shares of the company have seen some major volatility recently.

So, to understand this better, let's take a closer look at what it does. Applied UV is a tech penny stock that focuses on acquiring and developing new technologies. These technologies are used in a variety of industries including healthcare, hospitality, and much more.

[Read More] Penny Stocks To Watch: Why Hillstream BioPharma (HILS) Is Moving Today

And, with its two wholly owned subsidiaries, SteriLumen and Munn Works, the company has a large amount of exposure to many budding industries right now. And with its UVC LED Lumicide platform, it is also showing promise as a player in fighting the pandemic. While it has seen a large number of ups and downs as of late, AUVI stock remains an interesting tech penny stock. So, whether it is worth adding to your list of penny stocks to or not, is up to you.

Sos Ltd. /zigman2/quotes/202902836/composite SOS -4.34%

/zigman2/quotes/226092395/composite
US : U.S.: NYSE
$ 3.26
-0.48 -12.83%
Volume: 34.59M
Aug. 17, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$6.67 billion
Rev. per Employee
$489,605
loading...
/zigman2/quotes/220244459/composite
US : U.S.: Nasdaq
$ 1.79
+0.03 +1.70%
Volume: 303,381
Aug. 17, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$23.20 million
Rev. per Employee
$191,272
loading...
/zigman2/quotes/202902836/composite
US : U.S.: NYSE
$ 7.71
-0.35 -4.34%
Volume: 140,352
Aug. 17, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$45.91 million
Rev. per Employee
$2.14M
loading...
1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.